Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

Lendrem D, Mitchell S, McMeekin P, Gompels L, Hackett K, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; UK primary Sjögren’s Syndrome Registry.

Rheumatology (Oxford). 2015 Apr;54(4):655-9. doi: 10.1093/rheumatology/keu361. Epub 2014 Sep 19.

PMID:
25240612
2.

Health-related utility values of patients with primary Sjögren's syndrome and its predictors.

Lendrem D, Mitchell S, McMeekin P, Bowman S, Price E, Pease CT, Emery P, Andrews J, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Vadivelu S, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Ng WF; UK primary Sjögren's Syndrome Registry.

Ann Rheum Dis. 2014 Jul;73(7):1362-8. doi: 10.1136/annrheumdis-2012-202863. Epub 2013 Jun 12.

PMID:
23761688
3.

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.

Newton JL, Frith J, Powell D, Hackett K, Wilton K, Bowman S, Price E, Pease C, Andrews J, Emery P, Hunter J, Gupta M, Vadivelu S, Giles I, Isenberg D, Lanyon P, Jones A, Regan M, Cooper A, Moots R, Sutcliffe N, Bombardieri M, Pitzalis C, McLaren J, Young-Min S, Dasgupta B, Griffiths B, Lendrem D, Mitchell S, Ng WF; UK primary Sjögren's syndrome registry.

Ann Rheum Dis. 2012 Dec;71(12):1973-9. doi: 10.1136/annrheumdis-2011-201009. Epub 2012 May 5.

4.

Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.

Houseman M, Potter C, Marshall N, Lakey R, Cawston T, Griffiths I, Young-Min S, Isaacs JD.

Arthritis Res Ther. 2012 Feb 7;14(1):R30. doi: 10.1186/ar3734.

5.

Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards MH, McCrae FC, Young-Min SA.

Osteoporos Int. 2010 Apr;21(4):701-3. doi: 10.1007/s00198-009-0986-y. Epub 2009 Jun 27. Review.

PMID:
19562241
6.

Successful treatment of multicentric reticulohistiocytosis with leflunomide.

Lonsdale-Eccles AA, Haworth AE, McCrae FC, Young-Min SA.

Br J Dermatol. 2009 Aug;161(2):470-2. doi: 10.1111/j.1365-2133.2009.09227.x. Epub 2009 May 12. No abstract available.

PMID:
19438863
7.

Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.

Endean AL, Barry SM, Young-Min SA.

Rheumatology (Oxford). 2009 Mar;48(3):319-20. doi: 10.1093/rheumatology/ken469. Epub 2008 Dec 24. No abstract available.

8.

Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.

Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I.

Arthritis Rheum. 2007 Oct;56(10):3236-47.

9.

Gross synovial fluid analysis in the differential diagnosis of joint effusion.

Abdullah S, Young-Min SA, Hudson SJ, Kelly CA, Heycock CR, Hamilton JD.

J Clin Pathol. 2007 Oct;60(10):1144-7. Epub 2007 Jan 26.

10.

Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis.

Mewar D, Moore DJ, Young-Min S, Bertolaccini ML, Khamashta MA, Watson PF, Wilson AG.

Arthritis Rheum. 2005 Dec;52(12):3868-72.

11.

Weekly alendronate-induced acute pseudogout.

Young-Min SA, Herbert L, Dick M, Fordham J.

Rheumatology (Oxford). 2005 Jan;44(1):131-2. No abstract available.

12.

Copying clinic letters to patients will place additional demands on both secondary and primary care: a hospital outpatient questionnaire.

Young-Min SA, Hamilton J, Heycock C, Kelly C.

Rheumatology (Oxford). 2004 Oct;43(10):1306-7. No abstract available.

13.

CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy.

Young-Min S, Vaidya B.

Clin Rheumatol. 2004 Dec;23(6):568-9. No abstract available.

PMID:
15278761
14.

Modified Larsen scoring of digitized radiographs in rheumatoid arthritis.

Young-Min SA, Shakhapur S, Marshall N, Griffiths I, Cawston T, Grainger A.

J Rheumatol. 2003 Feb;30(2):238-40.

PMID:
12563674
15.

An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies.

Vaidya B, Pearce SH, Charlton S, Marshall N, Rowan AD, Griffiths ID, Kendall-Taylor P, Cawston TE, Young-Min S.

Rheumatology (Oxford). 2002 Feb;41(2):180-3.

16.

Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls.

Young-Min SA, Beeton C, Laughton R, Plumpton T, Bartram S, Murphy G, Black C, Cawston TE.

Ann Rheum Dis. 2001 Sep;60(9):846-51.

17.

Markers of joint destruction: principles, problems, and potential.

Young-Min SA, Cawston TE, Griffiths ID.

Ann Rheum Dis. 2001 Jun;60(6):545-8. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk